Non-healing wounds are extremely commonplace and it is estimated that over half a million people in the UK suffer from leg, foot and pressure ulcers which are categorised as non-healing. As well as being extremely painful, non-healing wounds can lead to further medical complications and in severe cases, can ultimately result in limb amputation.
The new treatment, which has been in development for seven years, involves the use of a medical wound dressing that produces small bio-electric currents around the site of a wound which mimics naturally occurring bio-electric currents. These currents have a vital role in wound healing and, if the right amount of electrical influence is delivered to the wound, it is possible to "kick start" the normal healing process. The product has undergone extensive testing and development and is sold under the POSiFECT® brand name.
For over thirty years scientists have been aware that cells, the basic building blocks of all living things, communicate with each other and are regulated by minute electric currents known as "bio-currents". It has been found that in some long-standing, non-healing wounds these normal electric currents are either absent or very weak. The new medical dressing features a micro-current delivery system which continuously and automatically adjusts the micro-current to levels clinically shown to initiate the wound healing process.
Managing non-healing leg ulcers and pressure ulcers alone costs the National Health Service in excess of £2 billion every year, and non-healing wounds cause pain and suffering for thousands of people. This represents about 4% of the entire NHS annual budget.
The new treatment will see patients use POSiFECT® in a seven week treatment regime, where they use the dressing for three weeks, changing the dressing every two to three days, before having a week not using the dressing. The process is then repeated for another three weeks. The treatment is painless and easy to use.
One woman who has already benefited from Posifect is 72 year old Marlene Jones from Basingstoke, Hampshire. She had a venous ulcer for ten months which despite extensive hospital treatment had persistently failed to heal. The ulcer was also causing her severe pain, which resulted in her having to take powerful painkillers on a daily basis.
She agreed to participate in an assessment of the POSiFECT® product and since receiving the treatment she has seen her ulcer halve in size in just a few weeks and the pain has reduced so much, she no longer has to take painkillers.
According to Marlene, "Every week I have the treatment I can see the ulcer reducing and it is now a fraction of its original size. The POSiFECT® dressing has also reduced my pain levels to such a point that I no longer need to take painkillers. I'm amazed by this treatment and I hope that more people who suffer from wounds such as mine will be able to benefit from it."
The study found that when patients suffering from abdominal mesothelioma were given a combination of two drugs, Alimta (pemetrexed) and Gemzar (gemcitabine), their condition improved. The following are the results of the study:
* Response rate among patients was 15 percent.
* The control rate of the disease for patients while on the medication was 50 percent.
* The median time to disease progression was 10.4 months.
* The median survival time was 26.8 months.
* The mesothelioma study involved 20 patients suffering from the condition.
In addition to the two drugs, the patients received dexamethasone, folic acid and vitamin B12. The study was conducted by researchers involved in a multi-center U.S. trial. Researchers expect to continue studying the drugs? effects on abdominal mesothelioma patients to determine if the treatment can be improved.
What is Abdominal Mesothelioma?
Abdominal mesothelioma is an extremely rare form of mesothelioma cancer. Commonly described as peritoneal mesothelioma, the cancer affects the abdominal lining, which is also known as the peritoneum. The serous membrane contains the parietal peritoneum, which continues on to the visceral peritoneum, which lines the organs; all of this is located in the abdominal cavity. With abdominal mesothelioma, the visceral and parietal peritoneum linings are affected with the development of cancerous cells.
Most often, abdominal cancer occurs when an individual first develops pleural mesothelioma, which is when the lining of the lung develops cancerous cells after inhalation of asbestos. Pleural mesothelioma can then spread to the peritoneal cavity and cause peritoneal mesothelioma, which accounts for less than one-third of all mesothelioma diagnoses.
How Does Someone Develop Abdominal Mesothelioma?
Abdominal, or peritoneal, mesothelioma is caused through the inhalation of asbestos fibers or asbestos dust. Asbestos is a material that is derived from vermiculite, a mineral that was mined heavily in the United States and around the world in the 20th century. Asbestos was most commonly used as an insulation within the construction industry because it was flame resistant and was developed at inexpensive prices.
An array of mild to severe mesothelioma symptoms exist, including:
* shortness of breath.
* inability to breath.
* fatigue.
* wheezing or severe cough.
Although, these symptoms are considered generalized for mesothelioma and do not represent specific types of the cancer. Additionally, there are a specific set of symptoms associated with abdominal mesothelioma. These symptoms are as follows:
* weight loss.
* abdominal swelling, which can be caused by ascites or the buildup of fluid in the abdominal cavity.
* bowel obstruction.
* fever.
* anemia.
* blood clotting.
* trouble swallowing.
* swelling of neck and face.
Abdominal Mesothelioma Treatment
Abdominal mesothelioma treatments commonly consist of surgical procedures to remove the infected cancerous areas. Often, the main surgery involved with peritoneal mesothelioma is known as cytoreductive surgery. While many individuals will receive specific treatments based on their case, the surgery usually is coupled with a chemotherapy treatment -- this treatment is often called the perioperative intraperitoneal chemotherapy and has been shown to slightly improve the median survival rate.
Obtaining Peritoneal Mesothelioma Legal Help
Individuals who have been diagnosed with peritoneal mesothelioma or any similar form of mesothelioma cancer are advised to locate an experienced mesothelioma attorney. Individuals who have been exposed to mesothelioma should contact a medical professional immediately because of the dangers that exist to even limited exposure to asbestos. These individuals may be able to receive monetary compensation for the extremely costly medical bills associated with abdominal mesothelioma.
It is especially important for an individual to seek legal counsel for their mesothelioma lawsuit if they were an employee within the metal, mining, maritime, construction and welding industries.
Both Arthor Pens & Peter Kent are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Arthor Pens has sinced written about articles on various topics from Affiliate Programs, Pets and Pets. For more information on treatment for non-healing wounds, visit: , specialists in the provision of skin treatments, products and service. Arthor Pens's top article generates over 90500 views. to your Favourites.
Peter Kent has sinced written about articles on various topics from Exhaust, Fitness and Health. For information on the various forms of mesothelioma, visit . Individuals can also visit. Peter Kent's top article generates over 40500 views. to your Favourites.